By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Affymetrix today commenced its tender offer to repurchase the entire $95.5 million aggregate principal amount of its 3.5 percent Senior Convertible Notes Due 2038 currently outstanding.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.
The New York Times' George Johnson muses on cancer's roots in multicellularity.
The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.
Jun Wang, the chief executive of BGI, has stepped down.